prx-112
Recombinant proteinexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2013 (NCT01747980)
Timeline
Indications
Studied for
Mechanism of action
- Beta-glucocerebrosidaseSupplementation
GBA supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- prx-112
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02107846 | Phase 2 | Apr 1, 2014 | Protalix |
| NCT01747980 | Phase 1 | Mar 1, 2013 | Protalix |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Protalix | For profit | 2 | 2 | 2 | 2013 |
1 organizations
Page 1 / 1